Patients with primary membranous nephropathy are at high risk of cardiovascular events

Taewoo Lee, Vimal K. Derebail, Abhijit V. Kshirsagar, Yunro Chung, Jason P. Fine, Shannon Mahoney, Caroline J. Poulton, Sophia Lionaki, Susan L. Hogan, Ronald J. Falk, Daniel C. Cattran, Michelle Hladunewich, Heather N. Reich, Patrick H. Nachman

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

Here we conducted a retrospective study to examine the risk of cardiovascular events (CVEs) relative to that of end-stage renal disease (ESRD) in patients with primary membranous nephropathy, in a discovery cohort of 404 patients. The cumulative incidence of CVEs was estimated in the setting of the competing risk of ESRD with risk factors for CVEs assessed by multivariable survival analysis. The observed cumulative incidences of CVEs were 4.4%, 5.4%, 8.2%, and 8.8% at 1, 2, 3, and 5 years respectively in the primary membranous nephropathy cohort. In the first 2 years after diagnosis, the risk for CVEs was similar to that of ESRD in the entire cohort, but exceeded it among patients with preserved renal function. Accounting for traditional risk factors and renal function, the severity of nephrosis at the time of the event (hazard ratio 2.1, 95% confidence interval 1.1 to 4.3) was a significant independent risk factor of CVEs. The incidence and risk factors of CVEs were affirmed in an external validation cohort of 557 patients with primary membranous nephropathy. Thus early in the course of disease, patients with primary membranous nephropathy have an increased risk of CVEs commensurate to, or exceeding that of ESRD. Hence, reduction of CVEs should be considered as a therapeutic outcome measure and focus of intervention in primary membranous nephropathy.

Original languageEnglish (US)
Pages (from-to)1111-1118
Number of pages8
JournalKidney International
Volume89
Issue number5
DOIs
StatePublished - May 1 2016
Externally publishedYes

Fingerprint

Membranous Glomerulonephritis
Chronic Kidney Failure
Incidence
Nephrosis
Kidney
Survival Analysis
Retrospective Studies
Outcome Assessment (Health Care)
Confidence Intervals

Keywords

  • cardiovascular disease
  • glomerulonephritis
  • membranous nephropathy

ASJC Scopus subject areas

  • Nephrology

Cite this

Lee, T., Derebail, V. K., Kshirsagar, A. V., Chung, Y., Fine, J. P., Mahoney, S., ... Nachman, P. H. (2016). Patients with primary membranous nephropathy are at high risk of cardiovascular events. Kidney International, 89(5), 1111-1118. https://doi.org/10.1016/j.kint.2015.12.041

Patients with primary membranous nephropathy are at high risk of cardiovascular events. / Lee, Taewoo; Derebail, Vimal K.; Kshirsagar, Abhijit V.; Chung, Yunro; Fine, Jason P.; Mahoney, Shannon; Poulton, Caroline J.; Lionaki, Sophia; Hogan, Susan L.; Falk, Ronald J.; Cattran, Daniel C.; Hladunewich, Michelle; Reich, Heather N.; Nachman, Patrick H.

In: Kidney International, Vol. 89, No. 5, 01.05.2016, p. 1111-1118.

Research output: Contribution to journalArticle

Lee, T, Derebail, VK, Kshirsagar, AV, Chung, Y, Fine, JP, Mahoney, S, Poulton, CJ, Lionaki, S, Hogan, SL, Falk, RJ, Cattran, DC, Hladunewich, M, Reich, HN & Nachman, PH 2016, 'Patients with primary membranous nephropathy are at high risk of cardiovascular events', Kidney International, vol. 89, no. 5, pp. 1111-1118. https://doi.org/10.1016/j.kint.2015.12.041
Lee, Taewoo ; Derebail, Vimal K. ; Kshirsagar, Abhijit V. ; Chung, Yunro ; Fine, Jason P. ; Mahoney, Shannon ; Poulton, Caroline J. ; Lionaki, Sophia ; Hogan, Susan L. ; Falk, Ronald J. ; Cattran, Daniel C. ; Hladunewich, Michelle ; Reich, Heather N. ; Nachman, Patrick H. / Patients with primary membranous nephropathy are at high risk of cardiovascular events. In: Kidney International. 2016 ; Vol. 89, No. 5. pp. 1111-1118.
@article{7f83ac8008884c6e8d52937df5372b13,
title = "Patients with primary membranous nephropathy are at high risk of cardiovascular events",
abstract = "Here we conducted a retrospective study to examine the risk of cardiovascular events (CVEs) relative to that of end-stage renal disease (ESRD) in patients with primary membranous nephropathy, in a discovery cohort of 404 patients. The cumulative incidence of CVEs was estimated in the setting of the competing risk of ESRD with risk factors for CVEs assessed by multivariable survival analysis. The observed cumulative incidences of CVEs were 4.4{\%}, 5.4{\%}, 8.2{\%}, and 8.8{\%} at 1, 2, 3, and 5 years respectively in the primary membranous nephropathy cohort. In the first 2 years after diagnosis, the risk for CVEs was similar to that of ESRD in the entire cohort, but exceeded it among patients with preserved renal function. Accounting for traditional risk factors and renal function, the severity of nephrosis at the time of the event (hazard ratio 2.1, 95{\%} confidence interval 1.1 to 4.3) was a significant independent risk factor of CVEs. The incidence and risk factors of CVEs were affirmed in an external validation cohort of 557 patients with primary membranous nephropathy. Thus early in the course of disease, patients with primary membranous nephropathy have an increased risk of CVEs commensurate to, or exceeding that of ESRD. Hence, reduction of CVEs should be considered as a therapeutic outcome measure and focus of intervention in primary membranous nephropathy.",
keywords = "cardiovascular disease, glomerulonephritis, membranous nephropathy",
author = "Taewoo Lee and Derebail, {Vimal K.} and Kshirsagar, {Abhijit V.} and Yunro Chung and Fine, {Jason P.} and Shannon Mahoney and Poulton, {Caroline J.} and Sophia Lionaki and Hogan, {Susan L.} and Falk, {Ronald J.} and Cattran, {Daniel C.} and Michelle Hladunewich and Reich, {Heather N.} and Nachman, {Patrick H.}",
year = "2016",
month = "5",
day = "1",
doi = "10.1016/j.kint.2015.12.041",
language = "English (US)",
volume = "89",
pages = "1111--1118",
journal = "Kidney International",
issn = "0085-2538",
publisher = "Nature Publishing Group",
number = "5",

}

TY - JOUR

T1 - Patients with primary membranous nephropathy are at high risk of cardiovascular events

AU - Lee, Taewoo

AU - Derebail, Vimal K.

AU - Kshirsagar, Abhijit V.

AU - Chung, Yunro

AU - Fine, Jason P.

AU - Mahoney, Shannon

AU - Poulton, Caroline J.

AU - Lionaki, Sophia

AU - Hogan, Susan L.

AU - Falk, Ronald J.

AU - Cattran, Daniel C.

AU - Hladunewich, Michelle

AU - Reich, Heather N.

AU - Nachman, Patrick H.

PY - 2016/5/1

Y1 - 2016/5/1

N2 - Here we conducted a retrospective study to examine the risk of cardiovascular events (CVEs) relative to that of end-stage renal disease (ESRD) in patients with primary membranous nephropathy, in a discovery cohort of 404 patients. The cumulative incidence of CVEs was estimated in the setting of the competing risk of ESRD with risk factors for CVEs assessed by multivariable survival analysis. The observed cumulative incidences of CVEs were 4.4%, 5.4%, 8.2%, and 8.8% at 1, 2, 3, and 5 years respectively in the primary membranous nephropathy cohort. In the first 2 years after diagnosis, the risk for CVEs was similar to that of ESRD in the entire cohort, but exceeded it among patients with preserved renal function. Accounting for traditional risk factors and renal function, the severity of nephrosis at the time of the event (hazard ratio 2.1, 95% confidence interval 1.1 to 4.3) was a significant independent risk factor of CVEs. The incidence and risk factors of CVEs were affirmed in an external validation cohort of 557 patients with primary membranous nephropathy. Thus early in the course of disease, patients with primary membranous nephropathy have an increased risk of CVEs commensurate to, or exceeding that of ESRD. Hence, reduction of CVEs should be considered as a therapeutic outcome measure and focus of intervention in primary membranous nephropathy.

AB - Here we conducted a retrospective study to examine the risk of cardiovascular events (CVEs) relative to that of end-stage renal disease (ESRD) in patients with primary membranous nephropathy, in a discovery cohort of 404 patients. The cumulative incidence of CVEs was estimated in the setting of the competing risk of ESRD with risk factors for CVEs assessed by multivariable survival analysis. The observed cumulative incidences of CVEs were 4.4%, 5.4%, 8.2%, and 8.8% at 1, 2, 3, and 5 years respectively in the primary membranous nephropathy cohort. In the first 2 years after diagnosis, the risk for CVEs was similar to that of ESRD in the entire cohort, but exceeded it among patients with preserved renal function. Accounting for traditional risk factors and renal function, the severity of nephrosis at the time of the event (hazard ratio 2.1, 95% confidence interval 1.1 to 4.3) was a significant independent risk factor of CVEs. The incidence and risk factors of CVEs were affirmed in an external validation cohort of 557 patients with primary membranous nephropathy. Thus early in the course of disease, patients with primary membranous nephropathy have an increased risk of CVEs commensurate to, or exceeding that of ESRD. Hence, reduction of CVEs should be considered as a therapeutic outcome measure and focus of intervention in primary membranous nephropathy.

KW - cardiovascular disease

KW - glomerulonephritis

KW - membranous nephropathy

UR - http://www.scopus.com/inward/record.url?scp=84964596900&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84964596900&partnerID=8YFLogxK

U2 - 10.1016/j.kint.2015.12.041

DO - 10.1016/j.kint.2015.12.041

M3 - Article

C2 - 26924046

AN - SCOPUS:84964596900

VL - 89

SP - 1111

EP - 1118

JO - Kidney International

JF - Kidney International

SN - 0085-2538

IS - 5

ER -